Ghia, P., Owen, C., Allan, J. N., Barrientos, J. C., Barr, P. M., Shi, C., . . . Burger, J. A. (2024). First‐line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age‐matched general population: A pooled post hoc analysis. Wiley. https://doi.org/10.1002/hem3.74
Cita Chicago Style (17a ed.)Ghia, Paolo, et al. First‐line Ibrutinib Treatment in Patients with Chronic Lymphocytic Leukemia Is Associated with Overall Survival Rates Similar to Those of an Age‐matched General Population: A Pooled Post Hoc Analysis. Wiley, 2024. https://doi.org/10.1002/hem3.74.
Cita MLA (9a ed.)Ghia, Paolo, et al. First‐line Ibrutinib Treatment in Patients with Chronic Lymphocytic Leukemia Is Associated with Overall Survival Rates Similar to Those of an Age‐matched General Population: A Pooled Post Hoc Analysis. Wiley, 2024. https://doi.org/10.1002/hem3.74.